Darutigenol ameliorates experimental colitis via promoting Akkermansia muciniphila-mediated proline synthesis
Here, the authors show that Darutigenol inhibits host IDO1 expression to drive A. muciniphila expansion and proline synthesis, thereby alleviating inflammation and presenting a potential strategy for IBD treatment.